Beyond Hydration: A Closer Look at ECM-Based Skin Boosters

The Pursuit of Healthy Skin Beyond Hydration

The pursuit of healthy, youthful-looking skin has long centered on hydration. Serums, skin boosters, and facial masks are designed to replenish moisture, helping skin appear smoother and plumper. However, hydration is only one part of the picture. Beneath the skin's surface lies the extracellular matrix (ECM), a gel-like 3D network of collagen, elastin, and other biomolecules that surrounds and supports skin cells.

As we age, this structural framework gradually deteriorates. "The ECM can be thought of as the skin's natural support system," said Dr Lam Bee Lan, medical director of Ageless Medical. "In younger skin, the ECM is dense, organised, and continuously renewed. With ageing, and through cumulative exposure to ultraviolet radiation, pollution, smoking, and other stresses, collagen becomes fragmented and reduced, elastic fibres become disorganised, and the skin's water-binding and repair mechanisms become less efficient. The communication between skin cells and their surrounding matrix is also impaired."

Regenerative Medicine Principles in Aesthetic Treatments

ECM-based biomaterials were first used in reconstructive surgery and wound management as biological scaffolds to support the body's healing and tissue remodelling processes. Their application in aesthetic treatments is based on the principle that cells do not function in isolation but constantly interact with their surrounding matrix. "The ECM's structure, composition, and mechanical properties can influence how cells attach, migrate, communicate, and participate in tissue repair," said Dr Lam.

A newer generation of skin boosters is applying regenerative medicine principles to target the ECM. One example is CellREDM, developed in South Korea. It is designed to deliver collagen, elastin, glycosaminoglycans (GAGs), and laminin into the dermis, the skin's thick middle layer, with the aim of supporting the skin's structural environment. CellREDM uses human acellular dermal matrix technology. Donated human dermal tissue undergoes medical-grade processing to remove living cells and cellular material while preserving collagen, elastin, GAGs, and laminin, which are formulated into injectable microparticles.

Multiple Ingredients, Multiple Benefits

Most conventional skin boosters rely on hyaluronic acid and are used mainly to improve hydration. ECM-based boosters are built around a different biological concept: They contain multiple components that are naturally found in healthy skin. Each component plays a distinct role. Collagen provides much of the dermis' structural support and tensile strength. Elastin helps skin stretch and return to its original shape. GAGs help regulate hydration, tissue cushioning, and the organisation of the ECM itself. Hyaluronic acid is one member of the GAG family. Laminin sits at the junction between the epidermis and dermis, supporting cell attachment, tissue organisation, and communication between cells and the surrounding matrix.

"Healthy skin is not made from one component. It is a highly organised biological system where different matrix molecules work together," said Dr Lam. "A multi-component injectable like CellREDM may resemble the complexity of native tissue more closely than an isolated ingredient."

What to Expect from Treatment

ECM-based skin boosters are administered by trained doctors using established injection techniques. CellREDM, which comes as a powder, is prepared according to the manufacturer's protocol before being injected into the dermis. Common treatment areas include the face, neck, and hands. The recommended protocol consists of three treatment sessions spaced about four weeks apart, though doctors may adjust this based on the patient's skin condition and clinical response. Mild redness, swelling, tenderness, or small injection marks are common afterwards and generally settle within several days. Maintenance treatments may be recommended every three to six months, depending on the individual's response and treatment goals.